Market Movers | Winners: FRVO, CRK, MMED | Losers: ALMS, ENOV, FBYD
A day of broad market declines saw extreme moves in individual stocks, raising questions about which trends have staying power.
Alumis (ALMS) was the weakest Market stock of the day, returning -56.6%. The move came as the S&P 500 returned -0.7%, the Dow Jones Industrial Average returned -0.8%, and the Nasdaq-100 returned -1.3%.
The day’s extremes raise a familiar question for any disciplined investor: is a single, sharp move the beginning of a story, or the end of one? The names below show both patterns at work.
Tuesday’s Market Winners
- Karman Stock: 12 Straight Red Days, Down 34%
- How Will Guidewire Software Stock React To Its Upcoming Earnings?
- How Will Samsara Stock React To Its Upcoming Earnings?
- Heico Stock Extends A 7-Day Losing Streak To An 8.4% Loss
- How Will Zscaler Stock React To Its Upcoming Earnings?
- 9 Red Days In A Row: BridgeBio Pharma Stock Is Down 8.8%
The 10 stocks with the highest returns on the last trading day:
| # | Ticker | Company Name | 1-D Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | FRVO | Fervo Energy | 28.4% | n/a |
| 2 | CRK | Comstock Resources | 11.0% | -30.9% |
| 3 | MMED | Minimed | 10.7% | n/a |
| 4 | MRNA | Moderna | 9.9% | 423.1% |
| 5 | ARCT | Arcturus Therapeutics | 9.9% | 164.7% |
| 6 | CTMX | CytomX Therapeutics | 9.2% | -13.8% |
| 7 | EIX | Edison International | 8.9% | 1.8% |
| 8 | LMB | Limbach | 8.7% | -42.5% |
| 9 | CBIO | Crescent Biopharma | 8.0% | 51.2% |
| 10 | NVAX | Novavax | 8.0% | 50.6% |
Tuesday’s Market Losers
And the 10 stocks with the lowest returns:
| # | Ticker | Company Name | 1-D Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | ALMS | Alumis | -56.6% | -3.0% |
| 2 | ENOV | Enovis | -16.5% | -22.9% |
| 3 | FBYD | Falcons Beyond Global | -16.2% | -50.1% |
| 4 | RPD | Rapid7 | -10.8% | -21.0% |
| 5 | OSW | OneSpaWorld | -10.4% | 7.9% |
| 6 | PS | Pershing Square | -10.3% | n/a |
| 7 | IE | Ivanhoe Electric | -9.3% | -37.2% |
| 8 | BW | Babcock & Wilcox Enterprises | -9.3% | 7.9% |
| 9 | SN | SharkNinja | -9.1% | 56.3% |
| 10 | EVCM | EverCommerce | -9.0% | -33.4% |
Today’s biggest loser has been losing for weeks.
Alumis (ALMS) appears on both the one-day and one-month losers lists. Its one-month return is -63.7%, and its weakness has been building for weeks; excluding today it still lost 16.5% over the other sessions. The company’s revenue declined 63.1% over the last twelve months, and its market value is about $1.2 billion.
Movers Over The Last Week
Widening the window to five trading days, these are the strongest and weakest Market names:
| # | Ticker | Company Name | 1-W Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | ANF | Abercrombie & Fitch | 29.2% | 11.8% |
| 2 | OKTA | Okta Inc. | 27.4% | 92.5% |
| 3 | CRM | Salesforce | 25.5% | -2.1% |
| 4 | CAPR | Capricor Therapeutics | 20.7% | -65.3% |
| 5 | CNXC | Concentrix | 20.1% | -19.2% |
| 6 | FRVO | Fervo Energy | 20.1% | n/a |
| 7 | MMED | Minimed | 18.5% | n/a |
| 8 | KVYO | Klaviyo | 17.3% | -36.4% |
| 9 | CRWD | CrowdStrike | 16.0% | 83.5% |
| 10 | ESTC | Elastic | 14.9% | 22.5% |
| # | Ticker | Company Name | 1-W Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | ALMS | Alumis | -60.5% | -3.0% |
| 2 | FBYD | Falcons Beyond Global | -33.5% | -50.1% |
| 3 | LPTH | LightPath Technologies | -31.3% | -12.3% |
| 4 | PCG | PG&E | -23.4% | -12.0% |
| 5 | FRMI | Fermi | -23.0% | -42.1% |
| 6 | BBW | Build-A-Bear Workshop | -22.8% | -49.7% |
| 7 | GENB | Generate Biomedicines | -22.5% | n/a |
| 8 | TRON | TRON Inc. | -22.3% | 32.3% |
| 9 | EIX | Edison International | -21.4% | 1.8% |
| 10 | AEHR | Aehr Test Systems | -19.9% | 279.3% |
Movers Over The Last Month
And over the last 21 trading days:
| # | Ticker | Company Name | 1-M Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | MRNA | Moderna | 179.8% | 423.1% |
| 2 | ARCT | Arcturus Therapeutics | 170.4% | 164.7% |
| 3 | CYPH | Cypherpunk Technologies | 168.5% | 47.4% |
| 4 | CAPR | Capricor Therapeutics | 138.3% | -65.3% |
| 5 | QMCO | Quantum | 128.9% | 274.7% |
| 6 | OABI | OmniAb | 126.5% | 140.0% |
| 7 | RCEL | AVITA Medical | 118.0% | 191.9% |
| 8 | ABCL | AbCellera Biologics | 93.5% | 229.8% |
| 9 | IOVA | Iovance Biotherapeutics | 91.9% | 203.3% |
| 10 | HTFL | HeartFlow | 88.5% | 73.0% |
| # | Ticker | Company Name | 1-M Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | ALMS | Alumis | -63.7% | -3.0% |
| 2 | EYPT | EyePoint | -63.1% | -74.9% |
| 3 | TDUP | ThredUp | -59.4% | -60.6% |
| 4 | UTI | Universal Technical Institute | -49.5% | -20.2% |
| 5 | AHCO | AdaptHealth | -49.1% | -44.7% |
| 6 | PLTK | Playtika | -45.8% | -44.3% |
| 7 | LINC | Lincoln Educational Services | -43.7% | 0.6% |
| 8 | GOGO | Gogo Inc. | -43.1% | -45.3% |
| 9 | CDNL | Cardinal Infrastructure | -42.9% | 48.9% |
| 10 | LASR | nLight | -42.5% | 7.5% |
A movers list is a map of attention, not a set of instructions.
The weekly and monthly tables earlier in this report show how quickly leadership can change, or how a trend can persist. A large move in either direction is simply information about risk and investor focus. The appearance of names like Moderna (MRNA) or Arcturus Therapeutics (ARCT) on both daily and monthly winner lists shows a trend, not an instruction. The disciplined follow-up is the same for any name, winning or losing: check the business behind the move.
The next step is never to trade the list; it is to test it. Our Guidance Momentum screen shows which risers have management raising guidance behind them, and our Buy the Dip screen shows which of the fallers still generate the growth and cash that make a recovery plausible.
Today’s Winner Is Tomorrow’s Loser Often Enough
The movers list is the most honest picture of single-stock risk the market prints each day: the same volatility that makes the winners column also fills the losers column, and no one reliably knows which side a stock lands on next.
That is the case for owning a disciplined basket instead of chasing the tape. The Trefis High Quality (HQ) Portfolio holds roughly 30 businesses selected for consistent cash generation, strong margins, and resilient balance sheets, sized and rebalanced with rules. It has a track record of outpacing a benchmark that combines the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Watch the movers for information; let the portfolio do the compounding.